Pharmacology and Toxicology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University, Mainz,Germany.
Department of Pharmacology, Biocenter, Goethe University, Frankfurt,Germany.
Curr Alzheimer Res. 2021;18(10):733-752. doi: 10.2174/1567205018666211208141512.
Alzheimer's disease (AD) is the most common progressive neurodegenerative disease. Today, AD affects millions of people worldwide and the number of AD cases will further increase with longer life expectancy. The AD brain is marked by severe neurodegeneration, such as the loss of synapses and neurons, atrophy and depletion of neurotransmitter systems, especially in the hippocampus and cerebral cortex. Recent findings highlight the important role of mitochondrial dysfunction and increased oxidative stress in the pathophysiology of late-onset alzheimer's disease (LOAD). These alterations are not only observed in the brain of AD patients but also in the periphery. In this review, we discuss the potential role of elevated apoptosis, increased oxidative stress and mitochondrial dysfunction as peripheral markers for the detection of AD in blood cells e.g. lymphocytes. We evaluate recent findings regarding impaired mitochondrial function comprising mitochondrial respiration, reduced complex activities of the respiratory chain and altered Mitochondrial Membrane Potential (MMP) in lymphocytes as well as in neurons. Finally, we will question whether these mitochondrial parameters might be suitable as an early peripheral marker for the detection of LOAD but also for the transitional stage between normal aging and Dementia, "Mild Cognitive Impairment" (MCI).
阿尔茨海默病(AD)是最常见的进行性神经退行性疾病。如今,AD 影响着全球数百万人,并且随着预期寿命的延长,AD 病例的数量将进一步增加。AD 大脑的特征是严重的神经退行性变,例如突触和神经元的丧失、萎缩和神经递质系统的耗竭,尤其是在海马体和大脑皮层。最近的发现强调了线粒体功能障碍和氧化应激增加在迟发性阿尔茨海默病(LOAD)发病机制中的重要作用。这些改变不仅在 AD 患者的大脑中观察到,在周围组织中也观察到。在这篇综述中,我们讨论了升高的细胞凋亡、增加的氧化应激和线粒体功能障碍作为血液细胞(例如淋巴细胞)中 AD 检测的外周标志物的潜在作用。我们评估了最近关于受损的线粒体功能的发现,包括线粒体呼吸、呼吸链复合物活性降低以及线粒体膜电位(MMP)改变在淋巴细胞和神经元中的情况。最后,我们将质疑这些线粒体参数是否可以作为 LOAD 的早期外周标志物,以及作为正常衰老和痴呆之间的过渡阶段“轻度认知障碍”(MCI)的检测标志物。